Abstract
Primary hepatocellular carcinoma (HCC) accounts for more than 5% of all cancers in the world, and causes between 250,000 and one million deaths globally each year. The incidence of portal vein thrombosis in HCC patients is around 8%. These patients are regarded as unsuitable for chemoembolization, especially if there is portal vein occlusion. The authors describe a patient with HCC and partial portal vein thrombosis who successfully underwent transarterial chemoembolization.
MeSH terms
-
Acrylic Resins / administration & dosage*
-
Aged
-
Carcinoma, Hepatocellular / complications
-
Carcinoma, Hepatocellular / therapy*
-
Chemoembolization, Therapeutic* / methods
-
Doxorubicin / administration & dosage*
-
Gelatin / administration & dosage*
-
Hodgkin Disease
-
Humans
-
Injections, Intra-Arterial
-
Liver Neoplasms / complications
-
Liver Neoplasms / therapy*
-
Male
-
Microspheres
-
Necrosis
-
Neoplasms, Second Primary / therapy*
-
Portal Vein*
-
Venous Thrombosis / etiology
-
Venous Thrombosis / therapy*
Substances
-
Acrylic Resins
-
trisacryl gelatin microspheres
-
Doxorubicin
-
Gelatin